SCHOOL TUITIONS
SAMIA DIDN’T THINK SHE’D EVER GET TO GO TO SCHOOL. HER PARENTS COULDN’T AFFORD THAT, BUT NOW WITH BASSMA’S SPONSORS AND VOLUNTEERS, SAMIA’S ENJOYING HER STUDIES...
School for Life

Bassma is launching the Easter-Ramadan Foodathon Campaign 2024!


Offer a Food pack, and/or a Hygiene pack, and/or a Bread pack.

 

During these hard times we are going through, solidarity is what matters the most.


Starting $30, you can make a difference in families' lives and draw smiles on their faces.


We count on your generous and precious support!

SOCIAL NEWS back
Thank you Rotary Club Beirut Cedars!
23. Jan 2021
Bassma Communication on Engagement 2020
25. Nov 2020
When President Macron meets few NGOs in ...
02. Sep 2020
UNDP Latest Poverty Assessment Report: 3...
17. Sep 2018
الكل في جريدة لنصنع وطنا
09. Feb 2018
The world's food import bill is rising d...
09. Nov 2017
WHO: One third of all women face violence
02. Jul 2013

source: www.who.int

 

Physical or sexual violence is a public health problem that affects more than one third of all women globally, according to a new report released by WHO in partnership with the London School of Hygiene & Tropical Medicine and the South African Medical Research Council.

The report, Global and regional estimates of violence against women: Prevalence and health effects of intimate partner violence and non-partner sexual violence, represents the first systematic study of global data on the prevalence of violence against women – both by partners and non-partners. Some 35% of all women will experience either intimate partner or non-partner violence. The study finds that intimate partner violence is the most common type of violence against women, affecting 30% of women worldwide.

The study highlights the need for all sectors to engage in eliminating tolerance for violence against women and better support for women who experience it. New WHO guidelines, launched with the report, aim to help countries improve their health sector’s capacity to respond to violence against women.

Impact on physical and mental health

The report details the impact of violence on the physical and mental health of women and girls. This can range from broken bones to pregnancy-related complications, mental problems and impaired social functioning.

“These findings send a powerful message that violence against women is a global health problem of epidemic proportions,” said Dr Margaret Chan, Director-General, WHO. “We also see that the world’s health systems can and must do more for women who experience violence.”

The report’s key findings on the health impacts of violence by an intimate partner were:

  • Death and injury – The study found that globally, 38% of all women who were murdered were murdered by their intimate partners, and 42% of women who have experienced physical or sexual violence at the hands of a partner had experienced injuries as a result.
  • Depression – Partner violence is a major contributor to women’s mental health problems, with women who have experienced partner violence being almost twice as likely to experience depression compared to women who have not experienced any violence.
  • Alcohol use problems – Women experiencing intimate partner violence are almost twice as likely as other women to have alcohol-use problems.
  • Sexually transmitted infections – Women who experience physical and/or sexual partner violence are 1.5 times more likely to acquire syphilis infection, chlamydia, or gonorrhoea. In some regions (including sub-Saharan Africa), they are 1.5 times more likely to acquire HIV.
  • Unwanted pregnancy and abortion – Both partner violence and non-partner sexual violence are associated with unwanted pregnancy; the report found that women experiencing physical and/or sexual partner violence are twice as likely to have an abortion than women who do not experience this violence.
  • Low birth-weight babies – Women who experience partner violence have a 16% greater chance of having a low birth-weight baby.

“This new data shows that violence against women is extremely common. We urgently need to invest in prevention to address the underlying causes of this global women’s health problem.” said Professor Charlotte Watts, from the London School of Hygiene & Tropical Medicine.

Need for better reporting and more attention to prevention

Fear of stigma prevents many women from reporting non-partner sexual violence. Other barriers to data collection include the fact that fewer countries collect this data than information about intimate partner violence, and that many surveys of this type of violence employ less sophisticated measurement approaches than those used in monitoring intimate partner violence.

“The review brings to light the lack of data on sexual violence by perpetrators other than partners, including in conflict-affected settings,” said Dr Naeemah Abrahams from the SAMRC. “We need more countries to measure sexual violence and to use the best survey instruments available.”

In spite of these obstacles, the review found that 7.2% of women globally had reported non-partner sexual violence. As a result of this violence, they were 2.3 times more likely to have alcohol disorders and 2.6 times more likely to suffer depression or anxiety – slightly more than women experiencing intimate partner violence.

The report calls for a major scaling up of global efforts to prevent all kinds of violence against women by addressing the social and cultural factors behind it.

Recommendations to the health sector

The report also emphasizes the urgent need for better care for women who have experienced violence. These women often seek health-care, without necessarily disclosing the cause of their injuries or ill-health.

“The report findings show that violence greatly increases women’s vulnerability to a range of short- and long-term health problems; it highlights the need for the health sector to take violence against women more seriously,” said Dr Claudia Garcia-Moreno of WHO. “In many cases this is because health workers simply do not know how to respond.”

New WHO clinical and policy guidelines released today aim to address this lack of knowledge. They stress the importance of training all levels of health workers to recognize when women may be at risk of partner violence and to know how to provide an appropriate response.

They also point out that some health-care settings, such as antenatal services and HIV testing, may provide opportunities to support survivors of violence, provided certain minimum requirements are met.

  • Health providers have been trained how to ask about violence.
  • Standard operating procedures are in place.
  • Consultation takes place in a private setting.
  • Confidentiality is guaranteed.
  • A referral system is in place to ensure that women can access related services.
  • In the case of sexual assault, health care settings must be equipped to provide the comprehensive response women need – to address both physical and mental health consequences.

The report’s authors stress the importance of using these guidelines to incorporate issues of violence into the medical and nursing curricula as well as during in-service training.

WHO will begin to work with countries in South-East Asia to implement the new recommendations at the end of June. The Organization will partner with ministries of health, non-governmental organizations (NGOs) and sister United Nations agencies to disseminate the guidelines, and support their adaptation and use.

Notes to Editors:

In March 2013, Dr Chan joined the UN Secretary General and the heads of other UN entities in a call for zero tolerance for violence against women at the Commission on the Status of Women in New York. During the Sixty-sixth World Health Assembly in May 2013, seven governments - Belgium, India, Mexico, Netherlands, Norway, United States of America, and Zambia - declared violence against women and girls "a major global public health, gender equality and human rights challenge, touching every country and every part of society" and proposed the issue should appear on the agenda of the Sixty-seventh World Health Assembly.

About the report

The report was developed by WHO, the London School of Hygiene & Tropical Medicine and the South African Medical Research Council. It is the first systematic review and synthesis of the body of scientific data on the prevalence of two forms of violence against women – violence by an intimate partner and sexual violence by someone other than an intimate partner. It shows for the first time, aggregated global and regional prevalence estimates of these two forms of violence, generated using population data from all over the world that have been compiled in a systematic way. The report documents the effects of violence on women’s physical, mental, sexual and reproductive health. This was based on systematic reviews looking at data on the association between the different forms of violence considered and specific health outcomes.

Regional data

The report represents data regionally according to WHO regions.

For intimate partner violence, the type of violence against women for which more data were available, the worst affected regions were:

  • South-East Asia - 37.7% prevalence. Based on aggregated data from Bangladesh, Timor-Leste (East Timor), India, Myanmar, Sri Lanka, Thailand.
  • Eastern Mediterranean - 37% prevalence. Based on aggregated data from Egypt, Iran, Iraq, Jordan, Palestine.
  • Africa – 36.6% prevalence. Based on aggregated data from Botswana, Cameroon, Democratic Republic of Congo, Ethiopia, Kenya, Lesotho, Liberia, Malawi, Mozambique, Namibia, Rwanda, South Africa, Swaziland, Uganda, United Republic of Tanzania, Zambia, Zimbabwe.

For combined intimate partner and non-partner sexual violence or both among all women of 15 years or older, prevalence rates were as follows:

  • Africa – 45.6%
  • Americas – 36.1%
  • Eastern Mediterranean – 36.4%* (No data were available for non-partner sexual violence in this region)
  • Europe – 27.2%
  • South-East Asia – 40.2%
  • Western Pacific – 27.9%
  • High income countries – 32.7%

For more information please contact:

Keletso Ratsela
South African Medical Research Council
Telephone: +27 12 339 8500, +27 82 804 8883
E-mail: [email protected]

Fadéla Chaib
WHO
Telephone: +41 22 791 3228
Mobile: +41 79 475 5556
E-mail: [email protected]

Jenny Orton/Katie Steels
London School of Hygiene & Tropical Medicine 
Telephone: +44 (0)20 7927 2802
E-mail: [email protected]

TERMS & AGREEMENTS
GOT A BRIGHT IDEA? SHARE IT!
Full Name
E-mail
Country
P.O.Box
City
Telephone number
Do you want to receive BASSMA�s Newsletter?
My bright idea
Fill all required fields
submit
cancel
Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat.

Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat. Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie consequat, vel illum dolore eu feugiat nulla facilisis at vero eros et accumsan et iusto odio dignissim qui blandit praesent luptatum zzril delenit augue duis dolore te feugait nulla facilisi.

 

Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat. Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie consequat, vel illum dolore eu feugiat nulla facilisis at vero eros et accumsan et iusto odio dignissim qui blandit praesent luptatum zzril delenit augue duis dolore te feugait nulla facilisi.

Enter your monthly salary
$
Enter your weekly working hours
hrs
0
0
0
.
0
0
ONE HOUR OF YOUR SALARY
Airtal.
Amlor 5mg.
Amolgal.
Androcur 10.
Augmentin.
Austin.
Bacazyme inj.
Bisoprolol Norman 5mg.
Cal C vita.
Capoten 25.
Cinarin 75 mg.
Cinemet.
Claritine.
Clenil forte.
Coltrate 600.
Coplixol.
Copoclen 25mg.
Depakine crono 500 mg.
Euro fer.
Lipentil.
Marvil 70.
Nazonex
Nexium 40mg.
Prozac 20mg.
Pulmozine
Rabezol 20mg
Risperdal
Seritide 250mg.
Seroxat.
Singular.
Sipriva
Solotik 100mg
Stilnox 10mg
Tavanic 500mg
Toby
Topamax 100 mg.
Venofer 100mg inj.

Get Adobe Flash player

This page requires Flash Player version 10.0.0 or higher.